Gilead Sciences Inc (NASDAQ:GILD)

115.04
Delayed Data
As of Jul 02
 -0.97 / -0.84%
Today’s Change
84.75
Today|||52-Week Range
123.37
+22.05%
Year-to-Date

Today’s Trading

Previous close116.01
Today’s open116.33
Day’s range114.91 - 116.49
Volume8,831,970
Average volume (3 months)10,904,339
Market cap$169.1B
Dividend yield1.50%
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+306.08%
Earnings growth (this year)+32.36%
Earnings growth (next 5 years)+11.10%
Revenue growth (last year)+121.81%
P/E ratio13.1
Price/Sales6.24
Price/Book11.18

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.73-1.12%
BIIBBiogen-1.13-0.28%
BXLTBaxalta Inc-0.47-1.49%
BAXBaxter International...-0.56-1.44%
Data as of 4:03pm ET, 07/02/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$2.64
Annual revenue (last year)$24.9B
Annual profit (last year)$12.1B
Net profit margin48.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers